Tumour-selective Salmonella-based cancer therapy

Biotechnology and Genetic Engineering Reviews

Volumn 18, Issue , 2001, Pages 219-233

  Bermudes, David ^a   Low, K Brooks ^b   Pawelek, John ^b   Feng, Ming ^a   Belcourt, Michael ^a   Zheng, Li Mou ^a   King, Ivan ^a  

^a Vion Pharmaceuticals Incorporated   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER THERAPY;

SALMONELLA;

CYTOSINE DEAMINASE; CYTOTOXIC AGENT; FLUCYTOSINE; FLUOROURACIL; NITROSOGUANIDINE; PRODRUG;

ANTINEOPLASTIC ACTIVITY; AUXOTROPHY; BREAST CARCINOMA; CANCER RADIOTHERAPY; CANCER THERAPY; COLON CARCINOMA; GENE THERAPY; GENETIC ENGINEERING; HUMAN; KNOCKOUT GENE; LUNG CARCINOMA; LUNG METASTASIS; MELANOMA; NONHUMAN; REVIEW; SALMONELLA; SUICIDE GENE; TUMOR XENOGRAFT; ULTRAVIOLET RADIATION; X IRRADIATION;

EID: 0034884624     PISSN: 02648725     EISSN: None     Source Type: Journal    
DOI: 10.1080/02648725.2001.10648014     Document Type: Review

References (41)

1. The effects of biochemical mutation on the virulence of Bacterium typhosum: The induction and isolation of mutants
2. The effects of biochemical mutation on the virulence of Bacterium typhosum: The virulence of mutants
3. The effects of biochemical mutation on the virulence of Bacterium typhosum: The loss of virulence of certain mutants
4. Tumor-targeted Salmonella. Highly selective delivery vectors
5. Tumor-targeted Salmonella: Strain development and expression of the HSV TK effector gene
6. Positive selection for loss of tetracycline resistance
7. Biodistribution and genetic stability of the novel anti-tumor agent VNP20009, a genetically modified strain of Salmonella typhimurium
8. Genetic delivery of enzymes for cancer therapy
9. Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector
10. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent
11. A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells
12. Monoclonal antibodies at age 20: Promise at last?
13. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts
14. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines
15. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant anti-tumor effects when only a small percentage of tumor cells express cytosine deaminase
16. Barriers to drug delivery in solid tumors
17. Complement evasion by bacteria and parasites
18. Radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase
19. Tumor-targeted Salmonella expressing cytosine deaminase converted 5-fluorocytosine to 5-fluorouricil and inhibited tumor growth in vivo
20. Tumor therapy using Salmonella
21. Bacterial genetic systems: Uses of transposons with emphasis on Tn10
22. Comparative evaluation of the acute toxic effects in monkeys, pigs, and mice of a genetically engineered Salmonella strain (VNP20009) being developed as an anti-tumor agent
23. Rapid mapping of conditional and auxotrophic mutations in Escherichia coli K-12
24. Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo
25. VNP20009, a genetically modified Salmonella typhimurium for treatment of solid tumors
26. Genetically modified Salmonella typhimurium inhibited growth of primary tumors and metastases
27. Radiosensitizing nucleosides
28. Characterization of aromatic- and purine-dependent Salmonella typhimurium: Attenuation, persistence, and ability induce protective immunity in BALB/c mice
29. Tumor-targeted Salmonella as a novel anticancer agent
30. Radiotherapy for Melanoma
31. Anti-tumor effects of genetically engineered Salmonella in combination with radiation
32. Chromosomal transformation of Escherichia coli recD- strains with linearized plasmids
33. Exploitable mechanisms in combined radiotherapy chemotherapy: The concept of additivity
34. Bacteriophage-mediated generalized transduction in Escherichia coli and Salmonella typhimurium
35. Use of preferentially replicating bacteria for treatment of cancer
36. Attenuated Salmonella typhimurium inhibited tumor metastasis in vivo